Daily Use Mobile Rubidium for Cardiac PET

Delivered straight to your practice

CDL CardioNavix is America's only provider of on‑demand Rubidium isotope for Cardiac PET. We bring a Rubidium generator to your healthcare facility when you need it.

Watch Video

The First And Only Patented On‑demand Mobile Rubidium

Bringing Rubidium-82 right to your doorstep

How it works

  • You reserve your day of service
  • CDL delivers the Rb-82 infusion system before your clinic opens
  • CDL removes the Rb-82 infusion system after your clinic closes
  • CDL provides training for physicians and staff

Why it matters

  • Allows scalability for your practice
  • Patients are scanned according to your daily schedule, with direct infusion giving you the capability to use as many doses as necessary

What We Provide

CDL CardioNavix is America’s only provider of on‑demand rubidium isotope for Cardiac PET.

  • Our solution allows hospitals, health systems, clinics, and IDTFs to use the available time on their existing PET or PET/CT equipment to offer Cardiac PET.
  • We can match our services to your frequency based on the availability of their PET/CT system and corresponding volume.
  • If you don’t have access to a PET/CT camera, CDL may be able to assist you with options for you and your patients.

Watch Video

Daily Use Mobile Rubidium For Cardiac PET

Benefits of Cardiac PET1

  • High diagnostic accuracy
  • Consistent high-quality images
  • Low radiation exposure
  • Short acquisition protocols
  • Quantification of myocardial blood flow
  • Strong prognostic power

Numbers that tell the difference

Study time2 and pharmacologic stress duration 3-5 hrs 20-30 mins
(50% coronary stenosis threshold)
81% 86%
(50% coronary stenosis threshold)
66% 100%
(50% coronary stenosis threshold)
76% 91%
Patient radiation exposure3 0.667 rads/6.67 mS v0.096 rads/.96mSv
  1. Bateman TM et al. J Nucl Cardiol. 2016;23: 1227-1231
  2. Bateman TM. J Nucl Cardiol. 2012;19: 3-11
  3. Bateman TM et al. J Nucl Cardiol. 2006;13: 24-33

Society Support for Cardiac PET


PET MPI has been shown to be the most accurate noninvasive test for assessment of suspected or known CAD. Other notable cardiac PET applications include inflammation imaging, infection assessment and viability assessment. These applications are helpful to the general cardiology community and for managing complex cases that often require multimodality imaging,"
Dr. Mouaz Al-Mallah, ASNC President
  • ASNC
Scenario  Recommended    Preferred
Prior poor quality stress imaging
Anticipated significant attenuation artifact
High-risk patient in whom diagnostic errors carry even greater clinical implications
Anticipated repeated radiation exposure to minimize exposure
Patients in whom myocardial blood flow quantification is identified by clinicians to be a needed adjunct to the image findings
Patient can’t complete a diagnostic level exercise stress imaging study


  • ACC
Class Of Recommendation   Level Of Evidence   Stress Testing
Class 1 (Strong) Level B-NR For intermediate-risk patients with acute chest pain and no known CAD who are eligible for cardiac testing, either exercise ECG, stress echocardiography, stress PET/SPECT MPI, or stress CMR is useful for the diagnosis of myocardial ischemia